Diabetic neuropathy. Other specified diabetes mellitus with neurological complications
Conditions
Interventions
Intervention 1: Control group: The conventional treatment method will continue (without receiving any new intervention). Intervention 2: Intervention group: Second group: The conventional treatment me
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Type 2 or type 1 diabetes with at least 5 years of diabetes history Having diabetic neuropathy of the lower extremities with a confirmed diagnosis by a neurologist Patients treated with conventional pharmacotherapy methods (including gabapentin, pregabalin, duloxetine, TCAs, and other drugs) for at least three months
Exclusion criteria
Exclusion criteria: Other lower limb problems and diseases History of any lower limb amputation Lower limb trauma Stroke history
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms (pain and heat, pressure sensation (monofilament), position, superficial and deep touch, paraesthesia, anesthesia, lower limb pulse). Timepoint: Before and 6 weeks after the intervention. Method of measurement: Clinical examination based on expert opinion.;Motor nerve conduction velocity. Timepoint: Before and 6 weeks after the intervention. Method of measurement: Nerve and leg muscle stripe test.;Neuropathic motor potential. Timepoint: Before and 6 weeks after the intervention. Method of measurement: Nerve and leg muscle stripe test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuropathic sensory potential amplitude. Timepoint: Before and 6 weeks after the intervention. Method of measurement: Nerve and leg muscle strip test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ebrahim Mohammmadi
Oroumia University of Medical Sciences
Outcome results
None listed